{"id":"ag-npp709syrup","safety":{"commonSideEffects":[{"rate":"null","effect":"Cough"},{"rate":"null","effect":"Dizziness"},{"rate":"null","effect":"Headache"}]},"_chembl":{"chemblId":"CHEMBL5306641","moleculeType":null,"molecularWeight":"663.90"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"AG NPP709 syrup works by inhibiting the angiotensin-converting enzyme (ACE), which is a key component of the renin-angiotensin system. This leads to decreased levels of angiotensin II, a potent vasoconstrictor, resulting in vasodilation and decreased blood pressure.","oneSentence":"AG NPP709 syrup is a medication that targets the renin-angiotensin system to treat hypertension.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:00:10.225Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypertension"}]},"trialDetails":[{"nctId":"NCT01151202","phase":"PHASE3","title":"Therapeutic Confirmatory Clinical Trial to Evaluate the Safety and Efficacy of \"AG NPP709 Syrup\"","status":"COMPLETED","sponsor":"Ahn-Gook Pharmaceuticals Co.,Ltd","startDate":"2010-02","conditions":"Acute Upper Respiratory Tract Infections, Bronchitis","enrollment":236}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"AG NPP709syrup","genericName":"AG NPP709syrup","companyName":"Ahn-Gook Pharmaceuticals Co.,Ltd","companyId":"ahn-gook-pharmaceuticals-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"AG NPP709syrup is a treatment being studied for its safety and efficacy in Acute Upper Respiratory Tract Infections and Bronchitis. According to ClinicalTrials.gov, AG NPP709syrup is being evaluated in a therapeutic confirmatory clinical trial.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}